Rebecca Jane COX BROKSTAD

Rebecca Cox is professor in medical virology and head of the Influenza Centre at the University of Bergen and Haukeland University Hospital, Norway. She leads a team of 15 enthusiastic scientists. Rebecca Cox completed her Ph.D. in 1995 at the London Hospital Medical College, University of London, UK before post doc positions at Guys Hospital, UK and the University of Bergen, Norway. She has >30 years of experience of influenza work particularly in development and evaluation of influenza vaccines. During the COVID-19 pandemic she led studies on SARS CoV-2 infection and vaccination and long term follow up of complications in Western Norway. She has served as an advisor to the World health Organisation, the European Union, the European Medicines Agency (EMA) and the Norwegian epidemic and pandemic committee. Her research focuses on development and evaluation of influenza vaccines with particular focus on human immune responses to infection and vaccination. She currently sits on the EMA Scientific working group on vaccines, the European Expert Group on SARS-CoV-2 variants and two influenza committees for the WHO. She is deputy chair of Influenza and Other Respiratory Viruses and senior editor for the journal Influenza and Other Respiratory Viruses. She is author of more than 150 peer-reviewed papers and regularly contributes to the public debate on Influenza, SARS CoV-2 and vaccines through multi-media channels.